文献速递神经肿瘤神经重症

高级别胶质瘤手术患者的血栓预防疗程:一项回顾性研究

Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.
PubMed 文献 · World Neurosurg · 2018-04-30

这项回顾性平行队列研究纳入301例接受次全或全切除的高级别胶质瘤成人患者,比较出院后继续预防性抗凝(达肝素21天)与短期预防(0-7天)对静脉血栓栓塞症(VTE)和颅内出血(ICH)的影响。多变量分析显示延长预防与VTE无显著关联,但与ICH发生相关。作者认为证据不足以将预防延长至出院后,需大规模随机前瞻性研究。

要点

  • 延长达肝素预防至21天与术后21天或90天VTE发生无显著关联。
  • 延长预防组ICH发生率为5.9%,短期组为0.6%,差异有统计学意义(P=0.03)。
  • 制动(P=0.03)和高体重指数(P=0.02)与VTE发生相关。

核心结论

  • 术后预防性抗凝21天与预防至出院相比未降低VTE发生率,且延长预防时ICH更常见;作者认为证据不足以将预防延长至住院之后,需大规模随机前瞻性研究明确安全性、疗效和最佳时机。

研究设计与样本

  • 回顾性平行队列研究,连续纳入单中心接受次全或全切除的成年高级别胶质瘤患者共301例。
  • 166例接受短期血栓预防(0-7天),135例接受延长血栓预防(达肝素21天)。
  • 采用多变量逻辑回归分析校正已知危险因素,评估预防时长与术后21天或90天内VTE及ICH发生的关联。

主要发现

  • 延长预防组与短期预防组术后21天VTE发生率分别为3.0%与1.2%,差异无统计学意义(P=0.24)。
  • 延长预防组与短期预防组术后90天VTE发生率分别为8.9%与4.8%,差异无统计学意义(P=0.09)。
  • 延长预防组与短期预防组ICH发生率分别为5.9%与0.6%,差异有统计学意义(P=0.03)。
  • 制动(P=0.03)和高体重指数(P=0.02)与VTE发生相关。

临床怎么用

  • 作者认为现有结果不足以支持将血栓预防延长至出院后,需大规模随机前瞻性研究明确高级别胶质瘤术后血栓预防的安全性、疗效和最佳时机。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-grade gliomas are associated with venous thromboembolism (VTE). This retrospective study with a parallel cohort design investigated influence of continuing prophylactic anticoagulation after discharge on rate of VTE and intracranial hemorrhage (ICH) in patients operated on for high-grade glioma. METHODS: Consecutive adult patients who underwent subtotal or gross total resection for high-grade glioma at a single institution were included. Multivariable logistic regression analysis was used to investigate the association between duration of thromboprophylaxis (dalteparin administered 21 days vs. 0-7 days) and occurrence of VTE and ICH within 21 or 90 days after surgery, corrected for known risk factors. RESULTS: Of 301 included patients, 166 received short-term thromboprophylaxis, and 135 received prolonged thromboprophylaxis. In multivariable analysis, prolonged thromboprophylaxis was not significantly associated with occurrence of VTE within 21 days (3.0% vs. 1.2%; P = 0.24) or 90 days (8.9% vs. 4.8%; P = 0.09) after surgery; however, prolonged prophylaxis was associated with occurrence of ICH (5.9% vs. 0.6%; P = 0.03). Additionally, immobility (P = 0.03) and high body mass index (P = 0.02) were associated with occurrence of VTE. CONCLUSIONS: Prophylactic anticoagulation for 21 days postoperatively was not associated with a decreased rate of VTE compared with thromboprophylaxis until discharge. ICH was more common with prolonged thromboprophylaxis. These results provide insufficient evidence to extend duration of prophylaxis beyond hospitalization. Large-scale randomized prospective studies are needed to clarify safety, efficacy, and optimal timing of postoperative thromboprophylaxis in patients with high-grade glioma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Senders JT, Snijders TJ, van Essen M, et al. Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study. World Neurosurg. 2018. PMID: 29715571. doi:10.1016/j.wneu.2018.04.151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。